These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3756880)

  • 41. Human mesenchymal stem cells from adipose tissue: Differentiation into hepatic lineage.
    Taléns-Visconti R; Bonora A; Jover R; Mirabet V; Carbonell F; Castell JV; Gómez-Lechón MJ
    Toxicol In Vitro; 2007 Mar; 21(2):324-9. PubMed ID: 17045453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multilineage differentiation potential of human dermal skin-derived fibroblasts.
    Lorenz K; Sicker M; Schmelzer E; Rupf T; Salvetter J; Schulz-Siegmund M; Bader A
    Exp Dermatol; 2008 Nov; 17(11):925-32. PubMed ID: 18557932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simplified culture techniques for growth and differentiation of murine and human pre-adipocytes for translational applications.
    Herrera-Herrera ML; Zapata-Bustos R; Salazar-Olivo LA
    Cytotherapy; 2009; 11(1):52-60. PubMed ID: 18972238
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro.
    Tholpady SS; Katz AJ; Ogle RC
    Anat Rec A Discov Mol Cell Evol Biol; 2003 May; 272(1):398-402. PubMed ID: 12704697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinoic acid-induced differentiation of the developmentally pluripotent human germ cell tumor-derived cell line, NCCIT.
    Damjanov I; Horvat B; Gibas Z
    Lab Invest; 1993 Feb; 68(2):220-32. PubMed ID: 7680083
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells.
    Rider DA; Dombrowski C; Sawyer AA; Ng GH; Leong D; Hutmacher DW; Nurcombe V; Cool SM
    Stem Cells; 2008 Jun; 26(6):1598-608. PubMed ID: 18356575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).
    Wang H; Scott RE
    Cell Prolif; 1993 Jan; 26(1):55-66. PubMed ID: 8439589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aproliferin--a human plasma protein that induces the irreversible loss of proliferative potential associated with terminal differentiation.
    Wier ML; Scott RE
    Am J Pathol; 1986 Dec; 125(3):546-54. PubMed ID: 3799819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Etiological factors, stages, and the role of the foreign body in foreign body tumorigenesis: a review.
    Brand KG; Buoen LC; Johnson KH; Brand I
    Cancer Res; 1975 Feb; 35(2):279-86. PubMed ID: 1089044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific expression of proteins and phosphoproteins in 3T3 T mesenchymal stem cells at distinct growth arrest and differentiation states.
    Sparks RL; Zschunke MA; Seibel-Ross EI; Tracy R; Zalitis JG; Boman BM; Hoerl BJ; Scott RE
    Cell Tissue Kinet; 1990 Mar; 23(2):71-87. PubMed ID: 2317836
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential.
    Wier ML; Scott RE
    J Cell Biol; 1986 May; 102(5):1955-64. PubMed ID: 2422182
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?
    Sell S
    Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):15-26. PubMed ID: 7516873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differentiation, cancer, and anticancer activity.
    Tzen CY; Estervig DN; Minoo P; Filipak M; Maercklein PB; Hoerl BJ; Scott RE
    Biochem Cell Biol; 1988 Jun; 66(6):478-89. PubMed ID: 3048326
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human squamous carcinoma cells express complex defects in the control of proliferation and differentiation.
    Scott RE; Wilke MS; Wille JJ; Pittelkow MR; Hsu BM; Kasperbauer JL
    Am J Pathol; 1988 Nov; 133(2):374-80. PubMed ID: 3056022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pathological process. III(IV). Cellular population systems as substrates of pathological processes: structure, reactivity, dynamics and basic lesions.
    Eskenasy A
    Morphol Embryol (Bucur); 1989; 35(3):173-94. PubMed ID: 2530443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune maintenance of self in morphostasis of distinct tissues, tumour growth and regenerative medicine.
    Bukovsky A
    Scand J Immunol; 2011 Mar; 73(3):159-89. PubMed ID: 21204896
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pathologist looks at spontaneous regression of cancer.
    Firminger HI
    Natl Cancer Inst Monogr; 1976 Nov; 44():15-8. PubMed ID: 193020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
    Scott RE; Hoerl BJ; Wille JJ; Florine DL; Krawisz BR; Yun K
    J Cell Biol; 1982 Aug; 94(2):400-5. PubMed ID: 6809770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biological mechanisms for the loss of the differentiated phenotype by non-terminally differentiated adipocytes.
    Hoerl BJ; Wier ML; Scott RE
    Exp Cell Res; 1984 Dec; 155(2):422-34. PubMed ID: 6209152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.